I move amendment No. 1:
To delete all words after "Dáil Éireann" and substitute the following:
"approves the Government's continuing and sustained commitment to implementing the National Cancer Strategy and welcomes the significant investment which the Government has made in enhancing patient care and in improving cancer-related services generally.".
I reject the motivation behind this Fine Gael motion which is clearly opportunistic and calculated to cause concern among a most vulnerable patient group. However, it provides me with the opportunity to put on record the significant resources in terms of infrastructure, personnel and services which this Government has put in place for cancer patients since the publication of the national cancer strategy.
This motion has been prompted by recent publicity concerning access to treatment by a patient in the Mater Hospital. It is not my intention to discuss the details of an individual patient's treatment as the provision of such treatment is a matter for the individual consultant and hospital concerned. It is unacceptable as a general principle for a patient's treatment to be disrupted and I know that Mater Hospital management has taken steps to ensure that the most immediate issues are addressed. I have already indicated that if there are resource issues to be addressed, I am willing to sympathetically consider any proposals I receive in the matter from the Eastern Regional Health Authority, the agency responsible for planning service needs in the area.
I am pleased to be given the opportunity tonight to outline the developments to date under the national cancer strategy and to brief the House on the areas of cancer services identified as priority areas for future development. The 1994 health strategy, Shaping a Healthier Future, set out a framework for the reorientation of our health care system. The reorganisation of our cancer treatment services was an integral part of this strategy and targets were set for reducing the mortality from cancer in the under-65 year age group by 15% in the period 1994 to 2004. Health care services were to be focused on improvements in health status and quality of life and increased emphasis was to be placed on the provision of the most appropriate care for patients.
Cancer was identified as one of the major sources of premature mortality in Ireland. The effect of cancer on health status in Ireland is striking. There was a clear need to address this and the national cancer strategy emerged as an evidence-based initiative to enable high quality cancer services to be developed throughout the country. The two principal objectives of the strategy are to take all measures possible to reduce rates of illness and death from cancer, in line with the targets established in Shaping a Healthier Future; and to ensure that those who develop cancer receive the most effective care and treatment and that their quality of life is enhanced to the greatest extent possible.
There are specific objectives in relation to key elements of the cancer strategy concerning such areas as prevention of cancers for which a cause is known or suspected; access to equitable, effective, quality services throughout the country; improved quality of life for patients; appropriate multidisciplinary treatment administered safely and in accordance with best practice guidelines; greater co-ordination of cancer treatment services from primary care to hospital care through to rehabilitation and palliative care; promotion of arrangements for appropriate research and education for those providing cancer services; and there should be a co-ordinated approach by all those involved in the care and treatment of patients with cancer to ensure that all services are provided in a cost effective manner.
Deputies will be aware that a range of support structures was put in place to co-ordinate and take a lead role in the implementation of the national cancer strategy. The first National Cancer Forum was established under the chairmanship of Professor James Fennelly. The forum, a multidisciplinary body, proved to be extremely useful and advised on many issues central to the successful implementation of the strategy. The term of office of the first forum expired last year and I subsequently appointed Professor Paul Redmond as the chairman of the second National Cancer Forum. The forum is currently examining a number of issues of tremendous importance to the effective progression of the development of cancer services in this country. Areas such as protocols for the care and treatment of cancer patients, information requirements, audit and evaluation of our services are all important com ponent parts of the appropriate future development of cancer services and the forum, as the established expert advisory body, will report to me on these issues.
Regional directors of cancer services were appointed in each health board area to oversee and co-ordinate the development of cancer services in their respective areas in conjunction with the chief executive officers of the health boards. I appointed regional directors of cancer services in each health board area last year and these posts are proving to be of great benefit in assisting in the development of appropriate future cancer services. I am pleased to report that considerable and tangible progress has been made to date under the national cancer strategy which has progressed beyond the original commitments made in the action plan for its implementation about which I will brief the House.
The implementation of the national cancer strategy was estimated to cost £25 million when it was launched. The sum allocated for the strategy in 1997 was £6 million. Since then, the Government has invested some £60 million in cancer prevention, treatment and care services, with £11 million being invested last year and almost £19 million being invested this year in such services. All of the commitments made in the action plan for the implementation of the strategy have been fully funded and have either been implemented or are in the course of implementation. The main implementation elements of the strategy included the areas of cancer prevention, early detection and screening, additional consultant appointments in key areas of cancer treatment and care and cancer research.
Cancers occur as a result of the interplay between genetic and environmental factors. Risk of cancer depends on age, sex, genetic make-up and where and how people live. To some extent, certain aspects of cancer risk are within our own control. There is strong evidence that lifestyle and environmental factors play an important role in the development of cancer. The use of tobacco, the excessive consumption of alcohol and unhealthy diet all contribute to increasing the risk of developing cancer. In spite of the fact that the EU directive on the banning of tobacco advertising was struck down, I successfully introduced legislation to ban the advertisement of tobacco in Irish newspapers and magazines. Contrary to Deputy Mitchell's assertion, the Minister for Finance is also keen to remove the cost of tobacco from the CPI but this matter is not within the Government's decision-making jurisdiction. Independent agencies must call for that. I am currently progressing this issue as it is a key factor in this country in the context of tobacco and alcohol alike.
It is important that the public is made aware of the scope for preventing many cancers by making appropriate lifestyle changes. To this end, the health promotion unit of my Department supports an extensive range of initiatives which have an impact on the levels of knowledge and aware ness of the risk factors associated with many cancers. These include mass media campaigns on anti-smoking, alcohol awareness and healthy eating. The unit also provides funding to the Irish Cancer Society in support of cancer prevention initiatives, including the yearly Europe Against Cancer campaign.
BreastCheck, the national breast screening programme, commenced in February 2000. Phase one of the programme covers the Eastern Regional Health Authority area, the North-Eastern and Midland Health Board areas. Screening is being offered free of charge to all women in the target age group of 50 to 64 years of age, on an area by area basis. In the period January to March 2001, approximately 2,700 women per month were screened at the BreastCheck units and approximately 700 per month were screened on the mobile unit. Less than l% of those screened are admitted to hospital for further management.
The board of BreastCheck has reviewed progress to date and has informed me it is pleased with the level of uptake in the areas screened to date. Uptake levels have virtually reached their target of 70%, while meeting the quality parameters set and providing evidence of a significant level of screen detected cancers. The successful roll-out of the programme is dependent on a number of factors, including the availability of appropriately trained staff. BreastCheck offers suitably skilled radiographers the opportunity to work in state of the art facilities in addition to an attractive employment package and the board has taken a number of initiatives, including an international advertising programme, to address the current shortage of suitably skilled radiographers.
BreastCheck, in conjunction with the school of diagnostic imaging at the Faculty of Medicine, UCD has also set up a post-graduate diploma in mammographic imaging, the first of its kind in Ireland. This joint initiative aims to increase levels of mammographic trained radiographers in Ireland and share the experiences of BreastCheck with other mammography services. The board of BreastCheck plans to carry out a national feasibility study on the availability of skilled staff for the programme and this is expected to be completed in a number of months. The board expects to provide me with recommendations regarding the extension of the programme to the rest of the country later this year. This is an area in which I am keenly interested but we must avoid rhetoric on this issue. We must not continue rolling out a campaign which is not appropriately backed up in terms of treatment centres etc. as to do so would be reckless and irresponsible.
There is a great deal of rationale behind the manner in which we are now progressing the BreastCheck programme. We are doing so on a proper professional basis so as to obtain the best results for the women of this country. I am committed to the extension of BreastCheck to ensure that women throughout the country have the highest quality breast screening services available to them. This involves, not only screening services, but also the availability of quality symptomatic services so that an equally high standard of hospital care is available for those who may require it following a screening detected cancer.
BreastCheck is providing an excellent, intensely quality-assured service for screened women who believe that they are healthy and for the treatment of women who, through screening, are discovered to have breast cancer. It is essential that this service be matched by an equally excellent service for those with symptomatic breast disease. As the plans for the commencement of BreastCheck progressed, it soon became apparent that the symptomatic breast cancer services in this country were not provided in the manner which would or should lead to the best outcomes for women. International experience tells us that women who are treated in a multidisciplinary centre, where all the relevant medical expertise is on one site and where there is a minimum number of patients with similar disease treated by the same team, have a greater chance of long-term survival and have less chance of their disease recurring than those treated in smaller centres. Having regard to these concerns, my predecessor Deputy Cowen, requested the National Cancer Forum to review symptomatic breast disease services nationally. The forum established a sub-group to undertake this task. The report on the Development of Services for Symptomatic Breast Disease was presented to me in April of last year. I accepted the broad thrust of this report and established an advisory group to meet with all the health boards to advise and assist in formulating regional plans for its implementation.
Concerns were raised in many areas because of a perceived notion that certain smaller hospitals around the country would be downgraded if they did not maintain their mammography services. I would like to stress to the House that this report was not about the downgrading or closure of any hospital. It is about the reorganisation and development of breast disease services in centres of excellence to ensure that every effort is made to reduce the number of women in this country who die from breast cancer every year. I want to assure Deputy Mitchell that I have bitten the bullet regarding this report and its recommendations despite the efforts of his senior colleagues who tried to sabotage the implementation of this report by scare tactics in localities across the country which did no service to the work of the sub-group regarding the centres of excellence. Nonetheless, I pressed ahead and have provided funding of more than £4 million this year to enable a number of agencies to commence the development of seven centres of excellence for the treatment of symptomatic breast disease. It is my intention to proceed with the remaining six centres in the Estimates for 2002. We are awaiting proposals from the health boards in that regard.
Phase One of the national cervical screening programme commenced in the Mid-Western Health Board in October 2000. Under the programme, in the region of 67,000 women of between 25 and 60 years of age will be screened, free of charge, at minimum intervals of five years. The question of extending the programme to the rest of the country is currently under consideration by my Department in conjunction with the chief executive officers of the health boards and the expert advisory group on cervical screening. A number of key consultant appointments were committed to under the National Cancer Strategy. All of the commitments made in the Action Plan have been met at this stage and additional appointments were made in the areas of medical oncology, histopathology, haematology and palliative care.
New consultant medical oncology appointments have been made or approved in the Eastern Regional Health Authority, Midland Health Board, Mid-Western Health Board, North-Eastern Health Board, North-Western Health Board, South-Eastern Health Board, Southern Health Board and the Western Health Board. Likewise, new consultant haematology appointments have been made or approved in the following areas: Midland Health Board, Mid-Western Health Board, North-Eastern Health Board, North-Western Health Board, South-Eastern Health Board, Southern Health Board and Western Health Board. In addition, I have provided funding of £2 million this year to the Eastern Regional Health Authority for the further development of oncology and haematology services.
New consultant histopathology appointments have been made or approved in the following areas: Eastern Regional Health Authority, Mid-Western Health Board, North-Eastern Health Board, North-Western Health Board, South-Eastern Health Board, Southern Health Board and the Western Health Board. New consultant appointments in the areas of palliative care have been made or approved in the following areas: Eastern Regional Health Authority, Mid-Western Health Board, North-Eastern Health Board, North-Western Health Board, South-Eastern Health Board and the Western Health Board. In addition, funding has been provided to the Midland Health Board for a palliative care consultant.
In addition to the appointment of palliative care consultants in the areas mentioned, the National Cancer Forum advised that as these important services were at an early stage of development in this country, it would be appropriate to obtain detailed advice on their further development. This Government's Action Programme for the Millennium contained a commitment to develop a national palliative care plan. In this context, a national review of palliative care services was undertaken under the chairmanship of Dr. Tony O'Brien, a report of which will be published in the near future. That in itself out lines a very significant degree of necessary investment.
In addition to the aforementioned consultant appointments, there have been additional consultant appointments resulting from the National Cancer Strategy as follows: two new consultant posts approved in the specialty of radiation clinical oncology at St. Luke's Hospital, Dublin and additional consultant surgeon appointments with special interest in breast disease and gastrointestinal disease in various locations throughout the country. More than 55 posts have been sanctioned since the Government took office as a result of an identified need and in a strategic manner. Everything we are doing under the cancer strategy is strategic by nature; it is not ad hoc, we are not filling in gaps as Deputy Mitchell suggested. It is strategic in terms of how we are rolling out the services, taking on the expert advice and providing the funding.